Advertisement
John Brenna, TOPEX President, stated "We are pleased with the RadiologyOncology Systems and Acceletronics business model and strong market positionproviding oncology product sales and ongoing customer service support."The agreement provides for exclusive territory distribution in New York, NewJersey, Maryland, Delaware, Virginia, West Virginia, Ohio, Indiana, Kentucky,Missouri, and Pennsylvania. The territory outside the United States includesMexico, Caribbean Countries, Central and South America.
Advertisement
Over 2.5M worldwide skin cancer cases are diagnosed annually at anincreasing rate. Increased exposure to the sun without protection and adecreasing natural ozone layer are cited as the chief causes of this increase-- a global problem!
The SRT 100 system provides an alternative to surgery for treating basalcell and squamous cell carcinomas, especially for primary lesions requiringdifficult or extensive surgery with sensitive structures in the head and neckregions -- the fold in the nose, eyelids, lips, corner of the mouth and thelining of the ear that would otherwise lead to a poor cosmetic outcome. Thistreatment does not require the use of anesthetics and eliminates the need forskin grafting when surgery could result in a less than desirable outcome. Thisprocedure also benefits those patients who have a fear of surgery or a needlephobia, for those patients who have contraindications for reconstructivesurgery that are taking anti-coagulants and blood thinners and for those thatcannot tolerate general anesthesia. This is a pain free procedure withexcellent cosmetic results and a well documented high cure rate. The insuranceindustry including Medicare part B widely accepts this procedure forreimbursement.
John Vano, President of Radiology Oncology Systems, Inc. confirmed, "ROSis very pleased to add the TOPEX SRT 100 to its line of radiation therapyproducts in selected markets. TOPEX has demonstrated its products areeffective, reliable, and cost-efficient. We believe the TOPEX line willprovide our customers an ability to provide superior patient care,cost-effectively, and we are excited to have the opportunity to introduce theproduct line to our customers and distributors in the U.S., Central and SouthAmerica."
Mike Summers, President and C.O.O. of Acceletronics, Inc., says "With thenew TOPEX superficial unit, Acceletronics is able to provide its customerswith a value-added, state of the art superficial treatment unit. Ourinternational team of field service engineers will allow us to install,service, and support TOPEX customers worldwide. We believe that TOPEX is anatural addition to our product and service offerings and welcome theopportunity to be of further service to the radiation oncology community."
TOPEX, Inc. is a medical device technology company focused on the design,manufacture and global distribution of a unique mobile superficial x-raysystem developed specifically for the treatment of skin cancer. The TOPEX SRT100 superficial radiotherapy system is designed to meet the clinical needs ofthe medical practitioner while providing an alternative treatment to surgeryfor the patient. The company is located in Danbury, CT. You can visit theirwebsite at www.topexmedical.com.
Radiology Oncology Systems, Inc. (ROS) is a leading medical equipmentsales and brokerage organization focused on radiation therapy and diagnosticimaging. ROS sells and supports a variety of used and refurbished equipmentpackages, including linear accelerator, IMRT and IGRT solutions, CT, and MRI.For more information, visit www.oncologysystems.com.
Acceletronics s
